What researchers published on Huntington-kór
5998 papers, newest first.
Showing 120 of 5998
Expression of Concern for SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington's disease models.The Journal of clinical investigation
Computer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.Pharmacological research
Psychometric validation of the Spanish version of the Huntington's Disease Health-Related Quality of Life Questionnaire (HDQoL©).Clinical neurology and neurosurgery
Repairing the disruption of protein homeostasis ameliorates REM sleep dysfunction in mouse models of Huntington's disease.Sleep
ÁttekintésPharmacological strategies to manage oxidative stress in Huntington's disease: from preclinical models to clinical trials.Frontiers in pharmacology
Superpixel-ComBat multi-site harmonization of unpaired T1W MRI data in Huntington's disease.Neuroimage. Reports
Interoception predicts empathy, social anxiety and quality of life in Huntington's disease.Journal of neurology
Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study.CNS spectrums
ÁttekintésMiro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.Mitochondrion
Qualitative insights from partners of individuals with Huntington's disease: the quality of life of an under-researched population.Orphanet journal of rare diseases
Primer site variations resulting in false-negative Huntington's disease testing.Journal of medical genetics
Isozyme-Specific Inhibition of GSK-3 Reveals Distinct Cellular Responses in Huntington's Disease Fibroblasts.Journal of neurochemistry
The SorCS2-derived macrocycle TT-P34 drives neuroprotection in animal models of neurodegeneration.Acta neuropathologica communications
ÁttekintésThe hepatic secretome-microglia axis in huntington's disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities.Metabolic brain disease
In vivo assessment of brain microstructure in patients with Huntington's disease using quantitative MRI.Journal of neurology
NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy
Forecasting and Dynamics of Huntington's disease: A Machine Learning approach for Fractional-Order Mathematical Model.Journal of advanced research
The Treatment of Psychiatric Symptoms in Huntington's Disease: A Systematic Review.Current neuropharmacology
Rhes as a Potential Modulator of PINK1/Parkin-Dependent Mitophagy in Huntington's Disease.Journal of integrative neuroscience
The postsynaptic scaffolding protein SAPAP3 shapes mitochondrial activity: the case of Huntington's disease.Cell death & disease
Cell-specific transcription dysregulation in human Huntington's disease-positive developing striatum.Brain : a journal of neurology
Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease.IET systems biology
CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
Computational modeling and preclinical evaluation support targeting somatic instability for Huntington's disease treatment.Nature communications
Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons.Cell
Multimodal spatial transcriptomics redefines cortical pathology in Huntington's disease.Cell
ÁttekintésNeuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation.IBRO neuroscience reports
Early Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington's Disease.Biology
Should Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?Movement disorders clinical practice
Quantifying multidisciplinary collaboration in Huntington's disease before and after service redesign: a social network analysis.BMC health services research
HD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.Movement disorders clinical practice
PreprintCerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease.medRxiv : the preprint server for health sciences
Randomizált vizsgálatAntidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.Neurology
Healthcare trajectories diverge years before Huntington disease is recorded in claims: a nationwide French matched cohort study.Journal of neurology, neurosurgery, and psychiatry
Emotion regulation difficulties are selectively associated with executive and behavioural apathy in Huntington's disease.Journal of neurology
Beyond Clinical Outcomes: What Antidopaminergic Medications Teach Us About Causal Inference in Huntington Disease.Neurology
Progenitor transcriptional alterations link fetal and adult pathology in Huntington's disease.Brain : a journal of neurology
ÁttekintésBeyond inherited repeat length: somatic expansions in Huntington disease.Current opinion in genetics & development
Cas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.Science translational medicine
ÁttekintésThe potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.Frontiers in molecular medicine
Autonomic dysfunction in patients with Huntington's disease: Evidence from standardized cardiovascular reflex testing.Journal of Huntington's disease
Huntington's disease clinical trials update: August 2026.Journal of Huntington's disease
ÁttekintésNeuroprotective Role of Withaferin A in Huntington's Disease: Current Evidence and Future Perspectives.Molecular neurobiology
The Power of Two: Combined MSH3/HTT Silencing in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
iPSC neurodegenerative disease initiative isogenic CAG repeat iPSC line for Huntington's disease.Journal of Huntington's disease
Attentional emotional bias in Huntington's disease: The "Hyper-Positive" effect.Cognitive, affective & behavioral neuroscience
Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.Movement disorders : official journal of the Movement Disorder Society
Recent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation.Reviews on recent clinical trials
Huntington's disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation.Nature communications
Unmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis.Clinical case reports
Role of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.Current neurovascular research
EsetismertetésJuvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.Annals of clinical and translational neurology
Striatal astrocyte μ-crystallin (Crym) loss contributes to early-stage Huntington's disease pathophysiology.Neuron
Plasma Lipid Remodeling across Preclinical Burden, Disease Onset, and Early Motor Severity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
PreprintEffect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD.medRxiv : the preprint server for health sciences
Safety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study.EClinicalMedicine
PreprintDepletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease.bioRxiv : the preprint server for biology
Pellagra encephalopathy in Huntington disease: An autopsy case.Journal of neuropathology and experimental neurology
Joint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time.Statistics in medicine
Staging disease without illness: ethical issues of the Huntington's Disease Integrated Staging System (HD-ISS).Journal of medical ethics
ÁttekintésMonitoring huntingtin aggregation in Huntington's disease: methods, challenges and future opportunities.Expert review of proteomics
ÁttekintésExtracellular Vesicles and Exosomes as Biomarkers in Huntington's Disease: Uncovering Pathogenic Insights and Pioneering Therapies.Molecular neurobiology
ÁttekintésHope or hype: novel disease-modifying treatments for Huntington disease.Parkinsonism & related disorders
Nationwide survey and epidemiology of Huntington's disease in Hungary.Neuroepidemiology
Lycium barbarum glycopeptide alleviates the neuropathology in Huntington's disease mouse models.Neural regeneration research
ÁttekintésChaperone-mediated remodelling of mutant huntingtin.Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ÁttekintésMechanistic Differences in Adult-Onset and Juvenile-Onset Huntington's Disease and the Potential Role of Neurodevelopment.Cureus
PreprintRestoring Aquaporin-4 alleviates molecular and motor phenotypes in zQ175 mouse model of Huntington's disease.bioRxiv : the preprint server for biology
PreprintComputer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.bioRxiv : the preprint server for biology
Agentic AI for Clinical Outcomes Research, Population Health Management Analyses With Large Administrative Databases, and Generating Epidemiological Estimates of Diseases: Feasibility and Validation Study.Journal of medical Internet research
ÁttekintésZebrafish as an Alternative Animal Model of Huntington's Disease: Challenges and Future Directions.Journal of integrative neuroscience
Development of Antisense Gapmers for the Treatment of Huntington's Disease.Methods in molecular biology (Clifton, N.J.)
Sex-dependent mild cardiac dysfunction and neurometabolic abnormalities in a model of Huntington's disease.Disease models & mechanisms
ÁttekintésEstrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease.Neurodegenerative disease management
Masking phosphatidylserine prevents neuronal loss in two distinct Drosophila models of neurodegeneration.Proceedings of the National Academy of Sciences of the United States of America
Expression of mutant Huntingtin induces proteasomal defects, mitochondrial abnormalities, and cell death in Drosophila muscles.Biochemical and biophysical research communications
ÁttekintésPlanning advanced therapy trials for Huntington's disease: Ethical considerations.Molecular therapy : the journal of the American Society of Gene Therapy
Correction: Remote smartphone-based spoken language screening predicts clinical markers in Huntington's disease.Journal of neural transmission (Vienna, Austria : 1996)
ÁttekintésUncovering hidden protein networks in Huntington's disease: implications for pathogenesis and therapy.Molecular biology reports
Exploring factors that influence meal management and eating behaviours in people living with Huntington's disease.Disability and rehabilitation
ÁttekintésDefective membrane dynamics in Huntington's disease: A role of Rab11 dysfunction.Journal of Huntington's disease
EsetismertetésChorea-predominant SCA5 mimicking Huntington's disease: A case report with a novel SPTBN2 variant.Clinical parkinsonism & related disorders
miR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington's disease.Journal of biomedical science
ÁttekintésFluid and Imaging Biomarkers in Huntington's Disease.Current neurology and neuroscience reports
ÁttekintésImaging the glymphatic system in Huntington's disease: The benefits of a multimodal approach and clinical implications.International review of neurobiology
ÁttekintésIndoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease.Biochimica et biophysica acta. Proteins and proteomics
uniQure Submits U.S., U.K. Applications for Huntington's Disease Candidate.Human gene therapy
Esketamine for treatment of depression in Huntington's disease: A case report.Journal of Huntington's disease
Meal timing as medicine: clinical evidence for intermittent fasting in Huntington's disease.Nature metabolism
Vizsgálati eredményEffects of time-restricted eating in early-stage Huntington's disease: a pilot study.Nature metabolism
Visualizing Synaptic Disruptions in the Release and Regulation of Dopamine Hotspots in Huntington's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience
An Atlas of Modifiers of Age at Onset in Huntington's Disease.Current neuropharmacology
Loss of interruption in the HTT CAG repeat is associated with somatic expansion and loss of medium spiny neurons in Huntington's disease.Neuron
Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.Journal of neurology
The Trail Making Test in healthy controls and Huntington's disease: Demographic effects and normative tables based on a large data set.Psychological assessment
Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease.Molecular biology reports
Neuroimaging Findings in Three Patients with Juvenile Huntington's Disease.AJNR. American journal of neuroradiology
ÁttekintésMicroRNAs in polyglutamine diseases: Mechanistic insights, circulating biomarkers, and emerging microRNA-based therapeutic strategies.Neurobiology of disease
Sesamum indicum-derived valdiate as a novel neuroprotective agent targeting PDE10A2 and SIRT1 in Huntington's disease.Frontiers in bioinformatics
Combining Lycopene, Quercetin, and Poloxamer 188 Therapy Reduces Learning and Memory Deficits in the 3-nitropropionic Acid-induced Rat Model of Huntington's Disease.CNS & neurological disorders drug targets
Identification of Age-Associated Upstream Regulators to Promote Neuronal Resilience in HD Patient-Derived Neurons.Neuroscience bulletin
Targeting Klotho Signaling for Neuroprotection in Huntington's Disease: A Comprehensive Review.Current molecular medicine
Nanotechnological and in vivo characterization of a new generation of brain-permeable nanoparticles for brain-targeted cholesterol delivery in Huntington's disease.International journal of pharmaceutics
Mapping brain volume changes in the zQ175DN mouse model of Huntington's disease: a longitudinal MRI study.Biomarker research
Psychological interventions for individuals affected by Huntington's disease: effects on depression, anxiety, and emotional well-being.Journal of community genetics
Cross-species single-cell atlas of the striatum defines cell-type and subregion disease vulnerabilities.Cell
Multimodal Characterization of Glymphatic-Related Magnetic Resonance Imaging Markers in Huntington's Disease: A Multi-Cohort Retrospective Study.Annals of neurology
Unawareness of motor deficit in Huntington's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Human-specific sequence features in HTT exon 1 promote toxic misprocessing via splicing factor SRSF7.Nature communications
L-theanine from Camellia sinensis (L.) attenuates 3-NP-induced Huntington's disease-like alterations by remedying behavioral patterns and modulating neurotransmitters across three distinct brain regions: evidence from in-vivo and in-silico approaches.Metabolic brain disease
A Cost-Effectiveness Analysis for Treatments of Patients with Early Stage Huntington's Disease in the USA.PharmacoEconomics - open
EsetismertetésEarly Manifestations, Diagnostic Pathways, and Epilepsy in Juvenile-Onset Huntington Disease: A Three-Patient Case Series and Systematic Review.Brain sciences
Early reduction of myelin-associated glycoprotein at myelin membranes in Huntington's disease.Experimental neurology
ÁttekintésRevealing the Mechanisms of Alzheimer's, Parkinson's and Huntington's Diseases Through Invertebrate Models.Biology
Geometric properties of caudate and putamen mark the progression of Huntington's disease.Imaging neuroscience (Cambridge, Mass.)
ÁttekintésThe pathophysiology of depression in Huntington's disease.Neuroscience and biobehavioral reviews
Decoding neuronal vulnerability: Multidimensional analysis of D1R- and D2R- medium-sized spiny neurons in Huntington's disease.Brain pathology (Zurich, Switzerland)
ÁttekintésUnraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders.Brain and behavior
A porcine spectral assay library to quantify brain proteome by DIA-MS.Scientific data
Network-based stratification of allele-specific expression reveals patient subgroups in Huntington's disease.Bioinformatics (Oxford, England)